[HTML][HTML] Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs
A Rezaee, PM Tehrany, FJ Tirabadi, N Sanadgol… - Biomedicine & …, 2023 - Elsevier
Brain tumors, which are highly malignant, pose a significant threat to health and often result
in substantial rates of mortality and morbidity worldwide. The brain cancer therapy has been …
in substantial rates of mortality and morbidity worldwide. The brain cancer therapy has been …
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
A Taheriazam, SD Bayanzadeh, MH Farahani… - European Journal of …, 2023 - Elsevier
Non-coding RNA transcripts are RNA molecules that have mainly regulatory functions and
they do not encode proteins. microRNAs (miRNAs), lncRNAs and circRNAs are major types …
they do not encode proteins. microRNAs (miRNAs), lncRNAs and circRNAs are major types …
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
L Turchi, N Sakakini, G Saviane, B Polo… - Cancers, 2023 - mdpi.com
Simple Summary Glioblastomas, primitive infiltrating brain tumors, are a real public health
problem because of their dismal prognosis. The persistence of aggressive tumor stem cells …
problem because of their dismal prognosis. The persistence of aggressive tumor stem cells …
miRNA-363-3p Hinders Proliferation, Migration, Invasion and Autophagy of Thyroid Cancer Cells by Controlling SYT1 Transcription to affect NF-κB
J Zhang, G Ren, T Huang, Y Sang… - … , Metabolic & Immune …, 2024 - ingentaconnect.com
Background: Thyroid cancer (TC) is a frequent endocrine malignant tumor with various
pathologic types. miRNA-363-3p plays a pivotal part in the occurrence, development …
pathologic types. miRNA-363-3p plays a pivotal part in the occurrence, development …
MicroRNAs, key regulators in glioma progression as potential therapeutic targets for Chinese medicine
H Fan, X Xie, X Kuang, J Du, F Peng - The American Journal of …, 2022 - World Scientific
Gliomas are tumors of the primary central nervous system associated with poor prognosis
and high mortality. The 5-year survival rate of patients with gliomas received surgery …
and high mortality. The 5-year survival rate of patients with gliomas received surgery …
Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis
Z Zhang, Y Mo, L Wu, X Wang, G Liao, W Tan… - Anti-Cancer …, 2022 - journals.lww.com
Previous studies have suggested that circular RNAs (circRNAs) are engaged in the
progression of papillary thyroid carcinoma (PTC). However, the mechanism of circ_0002111 …
progression of papillary thyroid carcinoma (PTC). However, the mechanism of circ_0002111 …
Novel cancer-fighting role of ticagrelor inhibits GTSE1-induced EMT by regulating PI3K/Akt/NF-κB signaling pathway in malignant glioma
E Lu, B Zhao, C Yuan, Y Liang, X Wang, G Yang - Heliyon, 2024 - cell.com
Background Glioma is the most common malignant brain tumor of the central nervous
system. Despite of the improvement of therapeutic strategy, the prognosis of malignant …
system. Despite of the improvement of therapeutic strategy, the prognosis of malignant …
The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort
Patients with high‐grade gliomas are at high risk of venous thromboembolism (VTE).
MicroRNAs (miRNAs) are small non‐coding RNAs with multiple roles in tumour biology …
MicroRNAs (miRNAs) are small non‐coding RNAs with multiple roles in tumour biology …
Role of microRNA-363 during tumor progression and invasion
A Nasimi Shad, I Akhlaghipour, HI Alshakarchi… - Journal of Physiology …, 2024 - Springer
Recent progresses in diagnostic and therapeutic methods have significantly improved
prognosis in cancer patients. However, cancer is still considered as one of the main causes …
prognosis in cancer patients. However, cancer is still considered as one of the main causes …
MicroRNA-429 overexpression overcomes imatinib resistance of glioma cells by negatively regulating lysophosphatidic acid receptor 1
J Xia, Z Peng, M Zhang, Q Liao, C Liu… - Neurological …, 2024 - Taylor & Francis
Background Glioma is one of the most aggressive and lethal malignancies in central
nervous system. It has been reported that miR-429 is declined in glioma and functions as a …
nervous system. It has been reported that miR-429 is declined in glioma and functions as a …